Form 4: Mersana Therapeutics SVP, Chief Legal Officer Alejandra Carvajal Reports Stock Sales to Cover Tax Obligations
SEC Form 4 Filing
Alejandra Carvajal, SVP, Chief Legal Officer of Mersana Therapeutics, reports the sale of common stock to cover tax obligations related to the vesting of restricted stock units.
Summary
- Alejandra Carvajal, SVP, Chief Legal Officer of Mersana Therapeutics, filed a Form 4 detailing changes in beneficial ownership.
- On October 1, 2024, Carvajal received 50,000 shares of common stock upon vesting of restricted stock units (RSUs) that were awarded on September 5, 2023.
- To cover tax withholding obligations associated with the vesting of these RSUs, Carvajal sold 8,089 shares on October 2, 2024, at an average price of $2 per share and 5,598 shares on October 3, 2024, at an average price of $1.96 per share.
- These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 10, 2023.
- Following these transactions, Carvajal directly owns 63,716 shares of Mersana Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock sales for tax purposes, which is neither particularly positive nor negative.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The sale of shares to cover tax obligations upon vesting of RSUs is a common practice.
Stakeholder Impact
- The stock sales may have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 2023-05-10 | Rule 10b5-1 trading plan adopted |
| 2023-09-05 | RSUs awarded to Reporting Person |
| 2024-10-01 | RSUs vested and shares of common stock received |
| 2024-10-02 | Shares of common stock sold |
| 2024-10-03 | Shares of common stock sold |
| 2024-10-07 | Date of Form 4 signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.